Investments in Basic Research for Pediatric Cancers: Developing Dinutuximab
NCI makes substantial investments in basic research, recognizing its fundamental importance in unraveling the complexities of pediatric cancers. A deeper understanding of cancer leads to new approaches for cancer prevention, screening, and treatment, like dinutuximab to treat neuroblastoma. Learn more about basic research in NCI’s Role in Cancer Research.
![](/sites/g/files/xnrzdm211/files/styles/cgov_article/public/cgov_infographic/100/100/6/files/basic-research-pediatric-enlarge.png?itok=vnyYJjX7)